Aeginis

Portfolio

Where the portfolio stands.

Every product is designed to be shelf-stable without refrigeration and to be tested for the stresses of spaceflight.

Pipeline
Crew-health products by stage
3In development
5Concept
6Research
Maturity
Technology readiness
Probiotic1Basic principles
2Concept formulated
3Proof of concept
MycoShell4Lab validation
5Relevant environment
6Prototype demo
7Operational demo
8System qualified
9Flight proven
Habitat · Flagship · TRL 4

MycoShell

A grown radiation shield. The building is the shield: no separate shielding payload, no separate structural payload.

  • Flat-packed, seeded scaffold
  • Grows with water and local regolith
  • Melanin-based gamma and proton attenuation
  • Doubles as water filtration and waste processing
  • Terrestrial spin-off: grown, sustainable construction material

Why shelf-stable

Space breaks ordinary supply chains.

In astronauts on 6 to 12 month ISS missions, gut, skin, nose and tongue microbes all shifted, with changes linked to skin rashes and immune alteration. Food degrades, medicines expire and no approved drug protects against deep-space radiation.

Shelf life
Storage life: need versus reality
Food shelf life Mars plans require
5 years
Typical medicine shelf life on the ISS (under)
<24 mo
Biologics, even refrigerated
~6 mo

Months of usable shelf life. Missions to Mars last years, with no resupply and no quick return home.

Spotlight

SpaceBiotic Spore Capsule

Built on bacterial spores, the format that kept more than a billion live organisms per capsule through a simulated 3-year Mars round trip in an independent study.

>1 billionlive organisms per capsule
3 yearssimulated Mars round trip
Room tempbarrier packaging, no fridge

Crew-health programme

Fourteen products, one idea: shelf-stable biology that works without a fridge.

In developmentConceptResearch programme
Research programme · TRL 1

Radioprotective probiotic

A synthetic-biology gut microbe designed to express Dsup-like and antioxidant radioprotective factors from within a crew member's own microbiome. At strain-design stage, it would complement MycoShell's ambient shielding with continuous internal protection. It carries the regulatory profile of a biologic, so it is deliberately parked behind MycoShell.

Decision support

Prioritised by Cosmion.

Each product is scored on evidence, technical risk, cost to test, regulatory path and mission relevance, so we know what to test next and why.

All products on this site are under research and development. They are not approved or cleared by any regulator and are not available for sale. Nothing here is medical advice, and no product is intended to diagnose, treat, cure or prevent any disease. Descriptions of research refer to published studies by other groups and do not claim that our products have been proven in space.

Let's build the next shield together.

Space agencies, station builders, research institutes and sustainable-construction partners: we would like to hear from you.